Steven E. Nissen

Steven E Nissen

Cleveland Clinic, Cleveland, US

Media

ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
EASD 22: SURMOUNT-MMO: Tirepatide in Obese Type II Diabetes Patients

Steven E Nissen,

Watch time: 7m 48s
ACC 22: Magnitude & Duration of Effects of a siRNA Targeting Lp(a)

Steven E Nissen,

Watch time: 3m 31s
ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall,

Watch time: 9m 1s
Celecoxib Integrated Safety Versus Ibuprofen Or Naproxen interview with Steven E. Nissen

Steven E Nissen,

Watch time: 4m 57s